Skip to main content
Premium Trial:

Request an Annual Quote

Cell Biosciences Raises $10M in Private Financing

NEW YORK (GenomeWeb News) – Cell Biosciences has raised $10 million through a Series C private financing, the Palo Alto, Calif.-based firm said today.

The company has developed an "ultrasensitive" nanofluidic immunoassay system designed to analyze proteins in very small biological samples. It said researchers can use the system to discover details about phosphoprotein signaling in a wide variety of biological systems.

Investors in the round included the firm's largest shareholder, the Wellcome Trust. Existing investors Domain Associates, Latterell Venture Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada, and the Vertical Group also participated in the round.

"This investment should allow us to fully execute our plan to bring this revolutionary proteomics technology to the broad life sciences market," Cell Biosciences CEO Tim Harkness said in a statement.

Cell Biosciences also noted that it will launch its next-generation protein analysis system, the CB1000, at the American Association for Cancer Research annual meeting in Denver later this month.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.